Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin.
Yiannakopoulou E.
Pharmacology. 2015;95(1-2):65-9. doi: 10.1159/000370245. Epub 2015 Jan 21.
[Microscopic polyangiitis].
Kogan EA, Saltykov BB, Radenska-Lopovok SG, Atanov PV.
Arkh Patol. 2020;82(5):63-66. doi: 10.17116/patol20208205163.
[Gangrenous granuloma].
ALAJMO E, FUSI G.
Boll Mal Orecch Gola Naso. 1955 Mar-Apr;73(2):166-84; contd.
IgG4-related skin disease.
Tokura Y, Yagi H, Yanaguchi H, Majima Y, Kasuya A, Ito T, Maekawa M, Hashizume H.
Br J Dermatol. 2014 Nov;171(5):959-67. doi: 10.1111/bjd.13296. Epub 2014 Oct 20.
[Gangrenous granuloma. II].
ALAJMO E, FUSI G.
Boll Mal Orecch Gola Naso. 1955 May-Jun;73(3):262-83.
Cell Liquefactive Necrosis.
Adigun R, Basit H, Zubair M, Murray J.
2025 Jan 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
[Midfacial gangrenous granuloma].
VARELA CHILESE R.
Bol Trab Soc Cir B Aires. 1959 Jul 29;43:476-7.
MR imaging of the diabetic foot.
Russell JM, Peterson JJ, Bancroft LW.
Magn Reson Imaging Clin N Am. 2008 Feb;16(1):59-70, vi. doi: 10.1016/j.mric.2008.02.004.
Granuloma gangraenescens.
PARDO-CASTELLO V, LEON BLANCO F, RIVERA DEL SOL R.
South Med J. 1953 Feb;46(2):149-55. doi: 10.1097/00007611-195302000-00010.
Malignant pyodermas.
Perry HO, Winkelmann RK, Muller SA, Kierland RR.
Arch Dermatol. 1968 Dec;98(6):561-76.
